1. Angus, DC, van der Poll, T. Severe sepsis and septic shock. N Engl J Med. 2013;369(9):840‐851.
Google Scholar | Crossref | Medline | ISI2. de Montmollin, E, Aboab, J, Mansart, A, Annane, D. Bench-to-bedside review: Beta-adrenergic modulation in sepsis. Crit Care. 2009;13(5):230.
Google Scholar | Crossref | Medline3. Leibovici, L, Gafter-Gvili, A, Paul, M, et al. Relative tachycardia in patients with sepsis: an independent risk factor for mortality. Qjm. Oct 2007;100(10):629‐634.
Google Scholar | Crossref | Medline4. Ali, NA, O‘Brien, JM, Dungan, K, et al. Glucose variability and mortality in patients with sepsis. Crit Care Med. 2008;36(8):2316‐2321.
Google Scholar | Crossref | Medline | ISI5. Lyons, PG, Micek, ST, Hampton, N, Kollef, MH. Sepsis-associated coagulopathy severity predicts hospital mortality*. Crit Care Med. 2018;46(5):736‐742.
Google Scholar | Crossref | Medline6. Sato, R, Ariyoshi, N, Hasegawa, D, et al. Effects of inotropes on the mortality in patients with septic shock. J Intensive Care Med. 2019:885066619892218.
Google Scholar | Medline7. Hasegawa, D, Sato, R, Prasitlumkum, N, et al. Effect of ultrashort-acting β-blockers on mortality in patients with sepsis with persistent tachycardia despite initial resuscitation: A systematic review and meta-analysis of randomized controlled trials. Chest. Jun 2021;159(6):2289‐2300.
Google Scholar | Crossref | Medline8. Tan, K, Harazim, M, Tang, B, McLean, A, Nalos, M. The association between premorbid beta blocker exposure and mortality in sepsis—a systematic review. Crit Care. 2019;23(1):298.
Google Scholar | Crossref | Medline9. Kuo, M, Chou, RH, Wu, CH, Huang, PH, Lin, SJ. Premorbid, cardioselective beta-blocker exposure decreases ICU mortality in septic patients defined by sepsis-3. Eur Heart J. 2020;41(Supplement_2).
Google Scholar | Crossref10. Tan, K, Harazim, M, Simpson, A, et al. Association between premorbid beta-blocker exposure and sepsis outcomes—the beta-blockers in European and Australian/American septic patients (BEAST) study. Crit Care Med. 2021; Latest Articles.
Google Scholar | Crossref11. Moher, D, Liberati, A, Tetzlaff, J, Altman, DG, Group, P. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. Ann Intern Med. 2009;151(4):264‐269. W264.
Google Scholar | Crossref | Medline | ISI12. Ouzzani, M, Hammady, H, Fedorowicz, Z, Elmagarmid, A. Rayyan—a web and mobile app for systematic reviews. Syst Rev. 2016;5(1):210.
Google Scholar | Crossref | Medline13. Bone, RC, Balk, RA, Cerra, FB, et al. Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. The ACCP/SCCM Consensus Conference Committee. American College of Chest Physicians/Society of Critical Care Medicine. Chest. 1992;101(6):1644‐1655.
Google Scholar | Crossref | Medline | ISI14. Levy, MM, Fink, MP, Marshall, JC, et al. 2001 SCCM/ESICM/ACCP/ATS/SIS International Sepsis Definitions Conference. Crit Care Med. 2003;31(4):1250‐1256.
Google Scholar | Crossref | Medline | ISI15. Singer, M, Deutschman, CS, Seymour, CW, et al. The Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3). JAMA. 2016;315(8):801‐810.
Google Scholar | Crossref | Medline | ISI16. Stang, A . Critical evaluation of the Newcastle-Ottawa scale for the assessment of the quality of nonrandomized studies in meta-analyses. Eur J Epidemiol. 2010;25(9):603‐605.
Google Scholar | Crossref | Medline | ISI17. Wan, X, Wang, W, Liu, J, Tong, T. Estimating the sample mean and standard deviation from the sample size, median, range and/or interquartile range. BMC Med Res Methodol. 2014;14(1):135.
Google Scholar | Crossref | Medline | ISI18. Higgins, JP, Thompson, SG. Quantifying heterogeneity in a meta-analysis. Stat Med. 15 2002;21(11):1539‐1558.
Google Scholar | Crossref | Medline19. Macchia, A, Romero, M, Comignani, PD, et al. Previous prescription of β-blockers is associated with reduced mortality among patients hospitalized in intensive care units for sepsis. Crit Care Med. 2012;40(10):2768‐2772.
Google Scholar | Crossref | Medline20. Contenti, J, Occelli, C, Corraze, H, Lemoël, F, Levraut, J. Long-term β-blocker therapy decreases blood lactate concentration in severely septic patients. Crit Care Med. 2015;43(12):2616‐2622.
Google Scholar | Crossref | Medline21. Arnautovic, J, Mazhar, A, Souther, B, Mikhijan, G, Boura, J, Huda, N. Cardiovascular factors associated with septic shock mortality risks. Spartan Med Res J. 2018;3(1):6516.
Google Scholar | Medline22. DeMott, JM, Patel, G, Lat, I. Effects of chronic antihypertensives on vasopressor dosing in septic shock. Ann Pharmacother. 2018;52(1):40‐47.
Google Scholar | SAGE Journals | ISI23. Chan, JZW, Tan, JH, Lather, KS, et al. Beta-blockers’ effect on Levels of Lactate in patients with suspected sepsis—The BeLLa study. Am J Emerg Med. 2020;38(12):2574‐2579.
Google Scholar | Crossref | Medline24. Pham, D, Ward, H, Yong, B, et al. Is lactate lower in septic patients who are prescribed beta blockers? Retrospective cohort study of an intensive care population. Emerg Med Australas. 2021;33(1):82‐87.
Google Scholar | Crossref | Medline25. Guz, D, Buchritz, S, Guz, A, et al. Beta-blockers, tachycardia and survival following sepsis—an observational cohort study. Clin Infect Dis. 2021.
Google Scholar | Crossref | Medline26. Hasegawa, D, Sato, R, Nishida, O. β1-blocker in sepsis. J Intens Care. 2021;9(1):39.
Google Scholar | Crossref | Medline27. Vieillard Baron, A, Schmitt, JM, Beauchet, A, et al. Early preload adaptation in septic shock? A transesophageal echocardiographic study. Anesthesiology. 2001;94(3):400‐406.
Google Scholar | Crossref | Medline28. Morelli, A, Ertmer, C, Westphal, M, et al. Effect of heart rate control with esmolol on hemodynamic and clinical outcomes in patients with septic shock: a randomized clinical trial. JAMA. 2013;310(16):1683‐1691.
Google Scholar | Crossref | Medline | ISI29. Gattinoni, L, Vasques, F, Camporota, L, et al. Understanding lactatemia in human sepsis. Potential impact for early management. Am J Respir Crit Care Med. 2019;200(5):582‐589.
Google Scholar | Crossref | Medline30. Garcia-Alvarez, M, Marik, P, Bellomo, R. Sepsis-associated hyperlactatemia. Crit Care. 2014;18(5):503.
Google Scholar | Crossref | Medline31. Levy, B, Fritz, C, Piona, C, et al. Hemodynamic and anti-inflammatory effects of early esmolol use in hyperkinetic septic shock: a pilot study. Crit Care. 2021;25(1):21.
Google Scholar | Crossref | Medline